Advertisement

Index by author

March 01, 1984; Volume 25,Issue 2

A

  1. Aman, R A

    1. Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

  2. Angel, L M

    1. Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;

  3. Armitage, I M

    1. Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;

B

  1. Barovsky, K

    1. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;

  2. Benkovic, S J

    1. Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
      L J Slieker and S J Benkovic
      Molecular Pharmacology March 1984, 25 (2) 294-302;

  3. Berger, S H

    1. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
      S H Berger and M T Hakala
      Molecular Pharmacology March 1984, 25 (2) 303-309;

  4. Brooker, G

    1. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;

  5. Bull, H G

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

  6. Bushfield, M

    1. Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;

C

  1. Cascieri, M A

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

  2. Catterall, W A

    1. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
      S W Postma and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 219-227;
    2. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;

  3. Conti-Tronconi, B M

    1. Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

D

  1. Dahlberg, W

    1. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

  2. Drummond, A H

    1. Thyrotropin-releasing hormone stimulates rapid breakdown of phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in GH3 pituitary tumor cells.
      C H Macphee and A H Drummond
      Molecular Pharmacology March 1984, 25 (2) 193-200;
    2. Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;

  3. Dumont, J E

    1. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

E

  1. Egan, E M

    1. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

  2. Ellestad, G A

    1. Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;

  3. Erneux, C

    1. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

F

  1. Fesik, S W

    1. Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;

  2. Fram, R J

    1. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

G

  1. George, J W

    1. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;

  2. Gould, R J

    1. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;

  3. Guidotti, A

    1. Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

H

  1. Hakala, M T

    1. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
      S H Berger and M T Hakala
      Molecular Pharmacology March 1984, 25 (2) 303-309;

  2. Highet, R J

    1. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;

  3. Hiller, J M

    1. Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;

  4. Holford, N H

    1. Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

  5. Hoyer, D

    1. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;

K

  1. Kageyama, H

    1. Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

  2. Kuenzel, E A

    1. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;

  3. Kufe, D W

    1. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

L

  1. Langry, K C

    1. The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;

  2. Liang, T

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

M

  1. Macphee, C H

    1. Thyrotropin-releasing hormone stimulates rapid breakdown of phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in GH3 pituitary tumor cells.
      C H Macphee and A H Drummond
      Molecular Pharmacology March 1984, 25 (2) 193-200;
    2. Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;

  2. McGahren, W J

    1. Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;

  3. Miot, F

    1. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

  4. Molinoff, P B

    1. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;

  5. Mumford, R A

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

  6. Murphy, K M

    1. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;

O

  1. Ortiz de Montellano, P R

    1. The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;

P

  1. Patchett, A A

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

  2. Pedone, C

    1. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;

  3. Pohl, L R

    1. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;

  4. Postma, S W

    1. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
      S W Postma and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 219-227;

R

  1. Reynolds, E E

    1. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;

  2. Richards, M L

    1. Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

  3. Rosenbaum, J S

    1. Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

S

  1. Sadée, W

    1. Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

  2. Saiani, L

    1. Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

  3. Schulick, R D

    1. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;

  4. Silver, P J

    1. Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.
      P J Silver and J T Stull
      Molecular Pharmacology March 1984, 25 (2) 267-274;

  5. Simon, E J

    1. Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;

  6. Slieker, L J

    1. Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
      L J Slieker and S J Benkovic
      Molecular Pharmacology March 1984, 25 (2) 294-302;

  7. Snyder, S H

    1. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;

  8. Stearns, R A

    1. The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;

  9. Stull, J T

    1. Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.
      P J Silver and J T Stull
      Molecular Pharmacology March 1984, 25 (2) 267-274;

T

  1. Thornberry, N A

    1. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

W

  1. Weichselbaum, R

    1. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

  2. Wells, J N

    1. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

  3. Willow, M

    1. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;
Back to top

In this issue

Advertisement